Literature DB >> 17536027

Systemic inflammation and progression of COPD.

Jørgen Vestbo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17536027      PMCID： PMC2117232          DOI： 10.1136/thx.2007.077792

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  16 in total

1.  Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.

Authors:  M Dahl; A Tybjaerg-Hansen; J Vestbo; P Lange; B G Nordestgaard
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

2.  Systemic inflammation and decline in lung function in a general population: a prospective study.

Authors:  Andrew W Fogarty; Stuart Jones; John R Britton; Sarah A Lewis; Tricia M McKeever
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

3.  Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study.

Authors:  Jørgen Vestbo; Eva Prescott; Thomas Almdal; Morten Dahl; Børge G Nordestgaard; Teis Andersen; Thorkild I A Sørensen; Peter Lange
Journal:  Am J Respir Crit Care Med       Date:  2006-01-01       Impact factor: 21.405

4.  C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease.

Authors:  S F P Man; J E Connett; N R Anthonisen; R A Wise; D P Tashkin; D D Sin
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

5.  Prognostic value of nutritional status in chronic obstructive pulmonary disease.

Authors:  C Landbo; E Prescott; P Lange; J Vestbo; T P Almdal
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

6.  C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.

Authors:  Morten Dahl; Jørgen Vestbo; Peter Lange; Stig E Bojesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  Am J Respir Crit Care Med       Date:  2006-10-19       Impact factor: 21.405

7.  Inflammatory response and body composition in chronic obstructive pulmonary disease.

Authors:  A A Eid; A A Ionescu; L S Nixon; V Lewis-Jenkins; S B Matthews; T L Griffiths; D J Shale
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

8.  Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study.

Authors:  Rafea Shaaban; Sabine Kony; Fathi Driss; Bénédicte Leynaert; David Soussan; Isabelle Pin; Françoise Neukirch; Mahmoud Zureik
Journal:  Respir Med       Date:  2006-05-02       Impact factor: 3.415

9.  Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patients.

Authors:  Hiroshi Kanazawa; Kazuto Hirata; Junichi Yoshikawa
Journal:  Chest       Date:  2003-02       Impact factor: 9.410

10.  Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.

Authors:  Don D Sin; S F Paul Man
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690
View more
  3 in total

1.  Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study.

Authors:  Seung Jun Lee; Hyang Rae Lee; Tae Won Lee; Sunmi Ju; Sujin Lim; Se-Il Go; Jung-Wan You; Yu Ji Cho; Gyeong-Won Lee; Yi Yeong Jeong; Ho Cheol Kim; Jong Deog Lee
Journal:  Korean J Intern Med       Date:  2016-03-25       Impact factor: 2.884

2.  Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy.

Authors:  Mickaël Martin; Natalie Almeras; Jean-Pierre Després; Harvey O Coxson; George R Washko; Isabelle Vivodtzev; Emiel Fm Wouters; Erica Rutten; Michelle C Williams; John T Murchison; William MacNee; Don D Sin; François Maltais
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-31

Review 3.  Epigenetic Alterations and Inflammation as Emerging Use for the Advancement of Treatment in Non-Small Cell Lung Cancer.

Authors:  Shuo Yang; Yang Huang; Qi Zhao
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.